Our graduate students are members of The George Washington University Institute for Biomedical Sciences (IBS), which offers an interdisciplinary educational and research training program leading to specialization in three different biomedical Ph.D. programs. Our Pharmacology & Physiology faculty are particularly active in the Pharmacology & Physiology, Neuroscience, and Molecular and Cellular Oncology tracks of the Molecular Medicine Ph.D. program. Choice of track is up to the student who selects a research mentor after completion of 3 laboratory rotations. Our students typically receive stipends of at least $21,000/year, as well as fully paid tuition benefits. Our graduates are now leaders at a variety of academic and pharmaceutical institutions, and include a number of Chairs of Departments, Vice Presidents, and a Nobel Laureate. To learn more about a particular track, please click here: Ph.D. in Molecular Medicine

 

NEW UNDERGRADUATE DEGREE PROGRAM IN PHARMACOGENOMICS

In collaboration with the GW Health Sciences Program and the School of Pharmacy of Shenandoah University , the Department has established a new bachelor's degree in Pharmacogenomics, the first of its kind in the country. Pharmacogenomics is a fast-breaking field in the Biomedical Sciences that examines interactions between therapeutic drugs and the human genome. In the near future, Pharmacogenomics will evolve into Personalized Medicine, the ability to use specific genomic information to routinely tailor drug therapy to individuals. This will improve patient care and markedly reduce the risks of adverse effects. Students trained in the Program will be very well prepared for careers in Pharmacy, Biomedical Research and Clinical Medicine. Interested students should contact the Associate Director of the Pharmacogenomics Program, Dr. Travis O'Brien (E-mail Dr. O'Brien) and visit the Pharmacogenomics Program website.